134 related articles for article (PubMed ID: 10196183)
21. Inter-molecular crosslinking activity is engendered by the dimeric form of transglutaminase 2.
Kim N; Lee WK; Lee SH; Jin KS; Kim KH; Lee Y; Song M; Kim SY
Amino Acids; 2017 Mar; 49(3):461-471. PubMed ID: 27394142
[TBL] [Abstract][Full Text] [Related]
22. Cross-linking of lipocortin I and enhancement of its Ca2+ sensitivity by tissue transglutaminase.
Ando Y; Imamura S; Owada MK; Kakunaga T; Kannagi R
Biochem Biophys Res Commun; 1989 Sep; 163(2):944-51. PubMed ID: 2571332
[TBL] [Abstract][Full Text] [Related]
23. Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles.
Yamane A; Fukui M; Sugimura Y; Itoh M; Alea MP; Thomas V; El Alaoui S; Akiyama M; Hitomi K
FEBS J; 2010 Sep; 277(17):3564-74. PubMed ID: 20716179
[TBL] [Abstract][Full Text] [Related]
24. Stable expression of transfected human involucrin gene in various cell types: evidence for in situ cross-linking by type I and type II transglutaminase.
Rorke EA; Eckert RL
J Invest Dermatol; 1991 Sep; 97(3):543-8. PubMed ID: 1678767
[TBL] [Abstract][Full Text] [Related]
25. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA.
Sugimura Y; Hosono M; Wada F; Yoshimura T; Maki M; Hitomi K
J Biol Chem; 2006 Jun; 281(26):17699-706. PubMed ID: 16636049
[TBL] [Abstract][Full Text] [Related]
26. Ectopic transglutaminase 1 and 3 expression accelerating keratinization in oral lichen planus.
Shimada K; Ochiai T; Hasegawa H
J Int Med Res; 2018 Nov; 46(11):4722-4730. PubMed ID: 30213231
[TBL] [Abstract][Full Text] [Related]
27. The transglutaminase activating metalloprotease inhibitor from Streptomyces mobaraensis is a glutamine and lysine donor substrate of the intrinsic transglutaminase.
Schmidt S; Adolf F; Fuchsbauer HL
FEBS Lett; 2008 Sep; 582(20):3132-8. PubMed ID: 18691578
[TBL] [Abstract][Full Text] [Related]
28. Facilitated wound healing by activation of the Transglutaminase 1 gene.
Inada R; Matsuki M; Yamada K; Morishima Y; Shen SC; Kuramoto N; Yasuno H; Takahashi K; Miyachi Y; Yamanishi K
Am J Pathol; 2000 Dec; 157(6):1875-82. PubMed ID: 11106560
[TBL] [Abstract][Full Text] [Related]
29. Formation of cornified cell envelope in human hair follicle development.
Akiyama M; Matsuo I; Shimizu H
Br J Dermatol; 2002 Jun; 146(6):968-76. PubMed ID: 12072064
[TBL] [Abstract][Full Text] [Related]
30. Novel transglutaminase inhibitors reduce the cornified cell envelope formation.
Kim SY; Park WM; Jung SW; Lee J
Biochem Biophys Res Commun; 1997 Apr; 233(1):39-44. PubMed ID: 9144392
[TBL] [Abstract][Full Text] [Related]
31. An extracellular transglutaminase is required for apple pollen tube growth.
Di Sandro A; Del Duca S; Verderio E; Hargreaves AJ; Scarpellini A; Cai G; Cresti M; Faleri C; Iorio RA; Hirose S; Furutani Y; Coutts IG; Griffin M; Bonner PL; Serafini-Fracassini D
Biochem J; 2010 Jul; 429(2):261-71. PubMed ID: 20441570
[TBL] [Abstract][Full Text] [Related]
32. Enzymatic cross-linking of involucrin and other proteins by keratinocyte particulates in vitro.
Simon M; Green H
Cell; 1985 Mar; 40(3):677-83. PubMed ID: 2578890
[TBL] [Abstract][Full Text] [Related]
33. Calcium modulates cornified envelope formation, involucrin content, and transglutaminase activity in cultured human ectocervical epithelial cells.
Kasturi L; Sizemore N; Eckert RL; Martin K; Rorke EA
Exp Cell Res; 1993 Mar; 205(1):84-90. PubMed ID: 8095904
[TBL] [Abstract][Full Text] [Related]
34. Transglutaminase 5 is acetylated at the N-terminal end.
Rufini A; Vilbois F; Paradisi A; Oddi S; Tartaglione R; Leta A; Bagetta G; Guerrieri P; Finazzi-Agro' A; Melino G; Candi E
Amino Acids; 2004 Jul; 26(4):425-30. PubMed ID: 15290349
[TBL] [Abstract][Full Text] [Related]
35. An involucrin-like protein in hepatocytes serves as a substrate for tissue transglutaminase during apoptosis.
Taresa E; Kedei N; Thomazy V; Fesus L
J Biol Chem; 1992 Dec; 267(36):25648-51. PubMed ID: 1361185
[TBL] [Abstract][Full Text] [Related]
36. Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation.
Ahvazi B; Kim HC; Kee SH; Nemes Z; Steinert PM
EMBO J; 2002 May; 21(9):2055-67. PubMed ID: 11980702
[TBL] [Abstract][Full Text] [Related]
37. Transglutaminase reactivity of human involucrin.
Lambert A; Ekambaram M; Robinson N; Eckert RL
Skin Pharmacol Appl Skin Physiol; 2000; 13(1):17-30. PubMed ID: 10657763
[TBL] [Abstract][Full Text] [Related]
38. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
Case A; Stein RL
Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
[TBL] [Abstract][Full Text] [Related]
39. Assays for transglutaminases in cell death.
Melino G; Candi E; Steinert PM
Methods Enzymol; 2000; 322():433-72. PubMed ID: 10914039
[TBL] [Abstract][Full Text] [Related]
40. Identification of preferred substrate sequences for transglutaminase 1--development of a novel peptide that can efficiently detect cross-linking enzyme activity in the skin.
Sugimura Y; Hosono M; Kitamura M; Tsuda T; Yamanishi K; Maki M; Hitomi K
FEBS J; 2008 Nov; 275(22):5667-77. PubMed ID: 18959752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
